NCT03486964View on ClinicalTrials.gov

Use of Incretins in Diabetic Patients

CompletedOBSERVATIONAL
Enrollment

2,234

Participants

Timeline

Start Date

March 27, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

May 30, 2021

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

DPP-4 inhibitors

Patients will be retrospectively evaluated after the addition of a DPP-4 inhibitor to previously taken anti-diabetic therapy

Trial Locations (1)

27100

IRCCS Policlinico San Matteo Foundation, Pavia

All Listed Sponsors
lead

University of Pavia

OTHER

NCT03486964 - Use of Incretins in Diabetic Patients | Biotech Hunter | Biotech Hunter